CSIR-IICT inks agreement with Bharat Biotech for novel vaccines platforms

05 April 2021 | News

To support the indigenous, affordable healthcare solutions for humans and animals

Image credit- shutterstock.com

Image credit- shutterstock.com

CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has inked an agreement with Hydrabad based Bharat Biotech International, Biovet, and Sapigen Biologix for the development of novel platform technologies for bio therapeutics and vaccines to support the indigenous, affordable healthcare solutions for humans and animals. The collaborators will identify the mutually interesting projects to be pursued under the agreement.

The industry collaborators shall provide necessary financial support to CSIR-IICT for developing key raw materials required by the collaborators, and also perform in-vitro and in vivo studies for further development of potential vaccine candidates and bio-therapeutics formulations to be designed by the collaborators. 

The partners intend to strengthen the excellent working relationship, by conducting studies on futuristic vaccines, bio-therapeutic formulations, delivery strategies and also explore innovative solutions to the vaccination administration process.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account